BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Monday, March 16, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 28, 1997
View Archived Issues
LifeCell issued U.S. patent for ThromboSol blood platelet preservation product
Read More
Antex Biologics allowed patents on adhesin receptor technology and H. influenzae protein
Read More
Exactech and the University of Florida Tissue Bank to codevelop biologic bone repair material
Read More
Discovery of potent and selective mu-opiate receptor agonists
Read More
Schering-Plough and Myriad Genetics enter into strategic collaboration
Read More
Sobel to acquire majority interest in Sidmak Laboratories
Read More
Matrix initiates phase II trial of IntraDose in liver cancer
Read More
Glaxo Wellcome discovers potent BAT inhibitor
Read More
Potent, metabolically stable cyclic urea HIV protease inhibitors under development at DuPont Merck
Read More
VIMRx completes phase I studies for VIMRxyn
Read More
Positive phase III results from Hyal's actinic keratosis trial
Read More
Cardiovascular Diagnostics and Lilly enter into development agreement
Read More
Novopharm and Glaxo Wellcome reach agreement for ranitidine
Read More
Altarex receives funding for photodynamic therapy for ovarian cancer research
Read More
Genelabs reports preliminary results from phase III trial of GL-701 for lupus
Read More
MedImmune's vaccine candidate prevents urinary tract infections in preclinical studies
Read More
Potential new treatments highlighted at recent periodontology symposium
Read More
Vascular Therapeutics reports positive safety and efficacy profile for Vasoflux
Read More
Emisphere receives notices of allowance for oral delivery technologies
Read More
Potent TNF inhibitor described by Celgene
Read More
Xoma and Pfizer discontinue U.S. phase III trial of E5
Read More
Parke-Davis SAR studies lead to potent, selective D4 antagonist
Read More
BioChem Pharma's novel flu vaccine meets phase I trial endpoints
Read More
RPR describes novel farnesyltransferase inhibitors
Read More
Amarillo Biosciences initiates clinical trial with interferon alfa in bone marrow disorders
Read More
Axcan receives IND approval for URSO in hypercholesterolemia
Read More
Matrix Pharmaceutical announces marketing partner for AccuSite in Spain and Portugal
Read More
